Tixagevimab

(Synonyms: AZD8895; COV2-2196)
Kundenbewertung

Based on 1 Customer Validation

Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.05%
  • CAS. Nr.: 2420564-02-7
  • Molecular Weight:146.48 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00